| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.049 | 0.7 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |